Session #1: SAA Gene Family: Structure and Diversity
- Discussion Leader: F.C. de Beer, University of Kentucky, Lexington
- A.S. Whitehead, Trinity College, Dublin: "Genetic and Evolutionary Analyses of the SAA Gene Family";
- Peter D. Gorevic, SUNY Stony Brook: "Sequence Analysis of Serum Amyloid A (SAA) Isoforms in Wild and Inbred Strains of Mice"
Session #2: Regulation of SAA Gene Expression
- Discussion Leader: W.S.L.Liao, M.D. Anderson Cancer Center
- P. Woo, Northwick Park Hospital, U.K.: "Regulation of Human SAA Genes";
- W.S.L. Liao, M.D. Anderson Cancer Center: "Transcription Factors in SAA Gene Regulation"
- A. Ray, University of Missouri, Columbia: "Analysis of a Novel Transcription Enhancer of an SAA Gene"
Session #3: SAA as an Apolipoprotein: Implications in Atherosclerosis I.
- Discussion Leader: A.M. Fogelman, UCLA
- C. Banka, Scripps Institute, La Jolla: " The Influence of Serum Amyloid A on HDL-Mediated Lipid Transport"
- A.M. Fogelman, UCLA: "Distribution and Quantitation of Antioxidant Enzymes in HDL"
Session #4: SAA as an Apolipoprotein: Implications in Atherosclerosis II.
- Discussion Leader: G. Getz, University of Chicago
- A.J. Lusis, UCLA, "Genetic Control of Inflammatory Responses in Atherosclerosis"
- L.L. Bausserman, Brown University, "Fate of Circulating SAA"
- M. Navab, UCLA , "Paraoxonase in HDL from the Fatty Lesion Prone Mice on an Atherogenic Diet Demonstrates Reduced Activity and Altered HDL Subclass Distribution"
Session #5: SAA in Amyloidosis: I. Current Perspectives
- Discussion Leader: M.D. Benson, Indiana University, Indianapolis
- M. Kindy, University of Kentucky, Lexington, "In Vivo Models for Amyloid Formation"
- J. Liepnieks, Indiana University, Indianapolis, "Heterogeneity of Amyloid A Protein in Human Secondary Amyloidosis"
Session #6: SAA Function
- Discussion Leader: J.D. Sipe, Boston University School of Medicine
- J.J. Oppenheim, National Cancer Institute, "Proinflammatory Activities of Serum Amyloid A (SAA)"
- L.D. Loose, Pfizer Inc., Groton, "Effect of Antirheumatic Therapy on SAA and Other Acute Phase Proteins in Patients With Either Osteoarthritis (OA) of Rheumatoid Arthritis (RA)"
Session #7: SAA in Amyloidosis and Atherosclerosis:Future Implications
- Discussion Leader: R. Kisilevsky, Queens University, Kingston
- B. Kluve-Beckerman, Indiana Univ Sch Med, "The Amino-terminal Domain of SAA: Relationship to HDL-binding and Amyloid Fibril Formation"
- R. Kisilevsky, Queens University, Kingston, "Function of Acute Phase Serum Amyloid A: A Peek Through an Amyloid Window"
|